• 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

8049 Share Price Performance

HK$2.05
0.55 (36.67%)
HK$2.05
0.55 (36.67%)
Price HK$2.05

8049 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and good value.

2 Risks
2 Rewards

Jilin Province Huinan Changlong Bio-pharmacy Company Limited Key Details

CN¥926.9m

Revenue

CN¥195.1m

Cost of Revenue

CN¥731.8m

Gross Profit

CN¥548.8m

Other Expenses

CN¥183.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.33
78.95%
19.74%
4.4%
View Full Analysis

About 8049

Founded
1989
Employees
798
CEO
Hong Zhang
WebsiteView website
www.jlchanglong.com

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets. It markets its products under the Changlong and Qing Tong brands. The company also engages in the manufacture and distribution of beverages and prepackaged food. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.

Recent 8049 News & Updates

Recent updates

No updates